Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/03/2012 | WO2012055607A1 Method for determining an analyte content of a liquid sample by means of a bioanalyzer |
05/03/2012 | WO2012055606A1 Method for determining an analyte content of a liquid sample by means of a bioanalyzer |
05/03/2012 | WO2012055554A1 Rapid method for targeted cell (line) selection |
05/03/2012 | WO2012055546A1 Wireless lance |
05/03/2012 | WO2012055541A1 Tgf-beta in the development of conventional dendritic cells and uses thereof |
05/03/2012 | WO2012055412A1 Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to nanoparticles |
05/03/2012 | WO2012055399A1 Method for creating the visual effect of a wood surface of a panel and panel with a wood surface |
05/03/2012 | WO2012055170A1 Use of cytoplasmic c-myc for regulating immune responses |
05/03/2012 | WO2012055096A1 Preparation method and use of anti-fgf-23 antibody |
05/03/2012 | WO2012055073A1 Method for setting temperature of polymerase chain reaction and instrument thereof |
05/03/2012 | WO2012055060A1 Method for electrical detection of biomolecules by metal dissolution and assay kit therefore |
05/03/2012 | WO2012055030A1 Clostridium difficile-specific antibodies and uses thereof |
05/03/2012 | WO2012054975A1 Method of microvesicle enrichment |
05/03/2012 | WO2012035296A3 Assay for prions |
05/03/2012 | WO2012033330A3 Measurement apparatus |
05/03/2012 | WO2012030305A3 Device and it system for remote and automatic pre-transfusion test interpretation |
05/03/2012 | WO2012027483A3 Defining diagnostic and therapeutic targets of conserved free floating fetal dna in maternal circulating blood |
05/03/2012 | WO2012024546A3 Incorporation of health measurments in analysis and interpretation of functional biological response data |
05/03/2012 | WO2012022734A3 Anti-icam-1 antibodies and methods of use |
05/03/2012 | WO2012021453A9 Evaluating anti-inflammatory responses |
05/03/2012 | WO2012018538A3 Bioassays for determining pd-1 modulation |
05/03/2012 | WO2012016021A3 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors |
05/03/2012 | WO2012015926A3 Devices and methods for filtering blood plasma |
05/03/2012 | WO2012012719A3 Mass spectrometric methods for quantifying npy 1-36 and npy 3-36 |
05/03/2012 | WO2012012709A3 Methods of detecting cardiovascular diseases or conditions |
05/03/2012 | WO2012012596A3 Force-induced magnetization contrast for diagnosis and imaging |
05/03/2012 | WO2012011660A3 Method of manufacturing micro chamber plate with built-in sample and analytic micro chamber plate, analytic micro chamber plate and apparatus set for manufacturing analytic micro chamber plate with built-in sample |
05/03/2012 | WO2012009550A3 Ultrasonic horn actuated microprobes based self-calibrating viscosity sensor |
05/03/2012 | WO2012008839A9 A method of analysing a blood sample of a subject for the presence of a disease marker |
05/03/2012 | WO2012003476A3 Hapten conjugates for target detection |
05/03/2012 | WO2011163116A3 CHRONIC LYMPHOCYTIC LEUKEMIA MODELED IN MOUSE BY TARGETED miR-29 EXPRESSION |
05/03/2012 | WO2011156740A3 Diagnosis of myocardial autoimmunity in heart disease |
05/03/2012 | WO2011154261A9 Compound screening based on sebum composition |
05/03/2012 | WO2011149233A3 Magnetic-nanoparticle/platinum-nanoparticle/porous-carbon composite and method for preparing same |
05/03/2012 | WO2011145905A3 Method for screening, using gaba receptors, for preparations for preventing fetal neural disease caused by alcohol exposure during pregnancy |
05/03/2012 | WO2011145885A3 Composition for screening and a screening method for substances active in treating hepatitis b |
05/03/2012 | WO2011123844A3 Markers and assays for detection of neurotoxicity |
05/03/2012 | WO2011110367A3 Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection |
05/03/2012 | WO2011092285A3 Means and methods for diagnosing heart failure in a subject |
05/03/2012 | US20120110682 Animal Model for Toxicology and Dose Prediction |
05/03/2012 | US20120109867 Pattern Discovery Techniques for Determining Maximal Irredundant and Redundant Motifs |
05/03/2012 | US20120109677 Blood bank management and rapid blood type determination system |
05/03/2012 | US20120109567 Systems and methods for acquiring and managing sensor data related to dissolution testing apparatus |
05/03/2012 | US20120109097 Recombinant il-9 antibodies and uses thereof |
05/03/2012 | US20120108935 Glucose sensor signal reliability analysis |
05/03/2012 | US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
05/03/2012 | US20120108790 Truncated Somatostatin Receptors |
05/03/2012 | US20120108662 Compositions and methods for treating skin disorders |
05/03/2012 | US20120108657 Disease-associated protein |
05/03/2012 | US20120108523 Disease-associated protein |
05/03/2012 | US20120108514 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof |
05/03/2012 | US20120108507 Methods for In Vivo Cell Reprogramming |
05/03/2012 | US20120108464 Test systems, methods and uses involving as160 protein |
05/03/2012 | US20120108461 High-throughput slide processing apparatus |
05/03/2012 | US20120108455 Methods for assessing and identifying or evolving conditionally active therapeutic proteins |
05/03/2012 | US20120108452 Semi-Invasive Method for Characterizing Lung Injury |
05/03/2012 | US20120108451 Methods and apparatus for nanoparticle-assisted nucleic acid hybridization and microarray analysis |
05/03/2012 | US20120108447 Methods of predicting clinical outcome in malignant melanoma |
05/03/2012 | US20120108444 Compositions and methods for detecting predisposition to a substance use disorder |
05/03/2012 | US20120107961 Magnetic sensor device, method of operating such a device and sample |
05/03/2012 | US20120107955 Metabolite biomarkers for the detection of esophageal cancer using ms |
05/03/2012 | US20120107954 Physiologic sample preparation for nanosensors |
05/03/2012 | US20120107953 Stabilization of interleukin 6 in serum based solutions |
05/03/2012 | US20120107948 Luminescent chemical sensor integrated with at least one molecular trap |
05/03/2012 | US20120107944 Holographic Sensor |
05/03/2012 | US20120107943 Labelling Strategies for the Sensitive Detection of Analytes |
05/03/2012 | US20120107940 Methods for Analyzing Polar Metabolites of the Energy Metabolism |
05/03/2012 | US20120107852 Method for preparing modified polypeptides |
05/03/2012 | US20120107851 Lateral flow assay device for coagulation monitoring and method thereof |
05/03/2012 | US20120107848 Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp |
05/03/2012 | US20120107847 Testing efficacy for celiac disease |
05/03/2012 | US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
05/03/2012 | US20120107845 Disrupting FCRN-Albumin Interactions |
05/03/2012 | US20120107843 Anti bone-loss and anti attachment-loss effects of an oral composition |
05/03/2012 | US20120107842 Method for detecting antibody against sith-1 in biological sample |
05/03/2012 | US20120107841 Serum Diagnostic Method, Biomarker and Kit for Early Detection and Staging of Alzheimer's Disease |
05/03/2012 | US20120107839 Nmr device for detection of analytes |
05/03/2012 | US20120107838 Cancer Diagnostics |
05/03/2012 | US20120107837 Method for screening anticancer substances, set or kit for implementing said method |
05/03/2012 | US20120107836 Development of fluorescently p-loop labelled kinases for screening of inhibitors |
05/03/2012 | US20120107835 Method for detecting beta-amyloid using amino acid dimers |
05/03/2012 | US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof |
05/03/2012 | US20120107832 Method for the detection of organ or tissue injury |
05/03/2012 | US20120107830 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy |
05/03/2012 | US20120107829 Stabilizing compositions for immobilized biomolecules |
05/03/2012 | US20120107828 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles |
05/03/2012 | US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use |
05/03/2012 | US20120107826 ZNF217 A New Prognostic And Predictive Biomarker Of Recurrent Invasive And Metastatic Phenotypes In Breast Cancer |
05/03/2012 | US20120107821 Methods for the diagnosis and prognosis of leukemia and other cancer types |
05/03/2012 | US20120107814 Method for Determining the Predisposition of a Patient to Changed Biotransformation and to the Development of Undesired Drug Effects in a Treatment of the Patient with Atrovastatin |
05/03/2012 | US20120107807 Highly sensitive method for the detection of cytosine methylation patterns |
05/03/2012 | US20120107803 Method for enumeration of mammalian micronucleated erythrocyte populations, while distinguishing platelets and/or platelet-associated aggregates |
05/03/2012 | US20120107802 Method for sequencing a heteropolymeric target nucleic acid sequence |
05/03/2012 | US20120107752 Systems, methods, and apparatus for determining airflow through a burner |
05/03/2012 | US20120107461 Seafood physical characteristic estimation system and method |
05/03/2012 | US20120107420 Methods of prognosis in chronic kidney disease |
05/03/2012 | US20120107402 Process for analyzing and establishing dosage size in an ingestible film |
05/03/2012 | US20120107390 Feline infectious peritonitis vaccine |
05/03/2012 | US20120107344 Composition for treatment of menopause |
05/03/2012 | US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |